Skip to content

Vibegron

Vibegron is a selective beta-3 adrenergic receptor agonist used primarily for the treatment of overactive bladder (OAB). It works by relaxing the detrusor muscle in the bladder, thereby reducing urinary urgency and frequency. While its direct impact on longevity is limited, managing OAB can significantly improve quality of life and reduce stress-related health issues.

Intelligence Profile

Science

Vibegron is a medication used to manage symptoms of overactive bladder (OAB). It works as a selective beta-3 adrenergic receptor agonist. By activating these receptors located primarily in the bladder's detrusor muscle, vibegron promotes relaxation of the bladder muscle, leading to an increase in bladder capacity and a reduction in symptoms like urgency, frequency, and incontinence.

The mechanism involves stimulating beta-3 adrenergic receptors, which are part of the sympathetic nervous system. Activation of these receptors results in the relaxation of the detrusor muscle during the storage phase of the bladder filling cycle. This allows the bladder to hold more urine and reduces involuntary contractions that cause the symptoms of OAB.

Several clinical trials and reviews underscore its efficacy in patients resistant to anticholinergic therapies and its tolerability in various populations, including older adults and specific pediatric cases with neurogenic bladder conditions.


This content is informational and not a substitute for professional medical advice. Always consult a healthcare provider for personalized care.